-+ 0.00%
-+ 0.00%
-+ 0.00%

Cellectis SA Outlines 2026 Strategy with Focus on Advancing Pivotal Phase 2 CAR-T Trials, Presenting Key Clinical Data, and Expanding Strategic Partnerships

Reuters·01/08/2026 21:30:17

Please log in to view news